Search the Newsreel

Kingstone (KINS) Q2 2026 Earnings Call Transcript

Trupanion CEO Margaret Tooth sells $28,410 in company stock By Investing.com

Trupanion CEO Margaret Tooth sold 978 shares of company stock for $28,410 on August 11, 2026, as part of a pre-scheduled diversification plan. Despite the stock trading 39% down over the past year, InvestingPro analysis suggests it is undervalued with a PEG ratio of …

Urbanise Sets Date for FY2026 Results and Investor Webinar

Trupanion CEO Margaret Tooth sells $28,410 in company stock

Trupanion CEO Margaret Tooth sold 978 shares of company stock for $28,410 on August 11, 2026, as part of a pre-scheduled diversification plan. Despite the stock trading 39% down over the past year, InvestingPro analysis suggests it is undervalued with a PEG ratio of …

Granite Ridge Resources (GRNT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Friday, Aug. 7, 2026 at 11 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations - James MastersPresident and Chief Executive Officer - Tyler FarquharsonChief Financial Officer - Kyle Kettler TAKEAWAYS Daily Production -- 32,044 barrels of oil equivalent …

Margaret Tooth Sells 978 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion CEO Margaret Tooth recently sold 978 shares of the company's stock for a total of $28,410.90 under a pre-arranged Rule 10b5-1 plan. Following the transaction, her ownership stands at 175,401 shares. The company's stock traded up 2.2% to $31.00, and Trupanion reported strong …

Orpheus Uranium Executes Sale Agreement to Acquire Adavale's Marree Embayment Uranium Portfolio

Janison to Release FY26 Results and Host Investor Webinar on 25 August

Orpheus Uranium to Expand Marree Footprint with Strategic Tenement Deal

Hovnanian Enterprises (HOV) Projected to Release Earnings on Thursday

Hovnanian Enterprises (HOV) is slated to release its Q3 2026 earnings before market open on Thursday, August 20th, with analysts forecasting a loss of $0.56 per share on revenue of $723.5 million. The company's previous quarter surpassed expectations, reporting negative $0.46 EPS against an …

Compañía Cervecerías Unidas S.A. 2026 Q2 - Results - Earnings Call Presentation (NYSE:CCU) 2026-08-13

Orpheus Uranium Expands Marree Footprint with Strategic Tenement Deal

Lexus Granito (India) Ltd is Rated Strong Sell

Manitowoc (MTW) Q2 2026 Earnings Call Transcript

ANI Pharmaceuticals Senior VP Meredith Cook Sells 500 Shares via 10b5-1 Trading Plan

Meredith Cook, Senior Vice President, General Counsel, and Secretary of ANI Pharmaceuticals Inc (NASDAQ:ANIP), sold 500 shares of the company's common stock on August 13, 2026. The sale, executed under a pre-established Rule 10b5-1 trading plan adopted on September 15, 2025, occurred at a …

Earnings call transcript: KinderCare Learning Q2 2026 miss sparks sharp selloff

KinderCare Learning Companies reported a Q2 2026 adjusted EPS of 8 cents, missing analyst estimates, while revenue was largely in line. The company's shares fell sharply after hours due to weaker profitability, a cut to full-year guidance, and ongoing center network optimization which includes …

Granite Construction Completes $273.7M Convertible Notes Conversion and Receives $148M from Capped Call Unwind

Granite Construction Incorporated announced the completion of the conversion of its $273.7 million 3.75% Convertible Senior Notes due 2028. The company issued 662,383 common shares and paid approximately $715 million in cash to settle these conversions. Additionally, Granite Construction received about $148 million from …

What's Going On With Guru Organic Energy Corp Stock Thursday?

Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Vivani Medical (NASDAQ:VANI) reported a quarterly loss of $0.07 per share, exceeding analyst estimates by $0.01. Despite beating expectations, shares fell 2.2% to $1.34. The company has an average "Hold" rating from analysts with a target price of $3.75, and director Gregg Williams recently …

Rani Therapeutics (NASDAQ:RANI) Announces Earnings Results, Beats Expectations By $0.01 EPS

KinderCare Learning Companies (NYSE:KLC) Posts Earnings Results, Misses Estimates By $0.02 EPS

KinderCare Learning Companies (NYSE:KLC) reported Q2 earnings of $0.08 per share, missing analyst estimates by $0.02, with revenue of $697.52 million also slightly below expectations. Despite the miss, the stock rose to $4.77, though the company continues to face financial risks including a negative …

Granite Construction issues shares to settle convertible notes and concludes capped call unwind

Granite Construction Inc. has issued 662,383 shares of common stock to settle $273.7 million in convertible senior notes, following a redemption call. The company also concluded capped call transactions, receiving approximately $148 million from financial institutions, which helped fund a $715 million cash payment …

Rani Therapeutics Q2 Results: EPS beats estimate, sales up 85%

Vivani Medical: Q2 Earnings Snapshot

KinderCare Learning Companies (NYSE:KLC) Updates FY 2026 Earnings Guidance

Rani Therapeutics Holdings earnings beat by $0.01, revenue topped estimates

Form 8K Granite Construction Inc For: 13 August By Investing.com

This article reports that Granite Construction Inc. filed a Form 8K on August 13. The brief news item also notes the current stock performance of GVA, showing a gain of 2.56%.

KinderCare Closes 49 Early Childhood Centers in Second Quarter

Rani Therapeutics (RANI) boosts liquidity with $20M raise and Chugai revenue

KinderCare Reports Second Quarter 2026 Financial Results

Second Quarter Highlighted by Continued Progress Across Key Growth Initiatives and Center Footprint Optimization. Company Updates Full-Year Outlook. LAKE OSWEGO, Ore., August 13, 2026--(BUSINESS WIRE)--KinderCare Learning Companies, Inc. (NYSE: KLC) ("KinderCare," the "Company," and "we"), a leading provider of high-quality early childhood education, today …

Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027

Vivani Medical (VANI) has reported a net loss of $6.4 million for Q2 2026 and $13.2 million for the first half of 2026, with cash and equivalents totaling $19.9 million, which is projected to fund operations into Q2 2027. The company is advancing its …

Form 8K Vivani Medical Inc For: 13 August By Investing.com

This article reports on the filing of a Form 8K by Vivani Medical Inc. on August 13th, as tracked by Investing.com. The brief mention indicates a financial disclosure event for the company, with the stock symbol VANI noted to have experienced a -2.19% change.

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update

Vivani Medical reported its second-quarter 2026 financial results, highlighting significant progress in its clinical development, including the successful dosing of all participants in its SLIM-1 Phase 1 trial for NPM-139, a semaglutide implant for chronic weight management. The company also announced a non-exclusive agreement …

20 Participants Dosed in Semaglutide Trial; Data Due in November

Vivani Medical (VANI) reported its Q2 2026 financial results, highlighting the successful dosing of all 20 participants in its Phase 1 SLIM-1™ trial for NPM-139, a semaglutide implant, with top-line data expected in November 2026. The company also announced a non-exclusive agreement with Novo …

Rani Therapeutics' Oral RT-114 Tops 150% Bioavailability

Rani Therapeutics reported its Q2 2026 financial results, including a net loss of $8.4 million and contract revenue of $1.7 million, with cash reserves of $53.4 million expected to fund operations through 2027. The company announced positive initial Phase 1a data for its oral …

Lowe's Cos. stock outperforms competitors on strong trading day

Lowe's Companies (LOW) stock increased by 1.04% to $218.22, outperforming the broader market which also saw gains in the S&P 500 and Dow Jones Industrial Average. Despite the positive trading day, the stock remains 25.54% below its 52-week high of $293.06.